TTM
$0.00
YoY change
—
5Y CAGR
-100.0%
Peak year (2019)
$50.04M
Cumulative revenue
$189.54M
Revenue history chart for Revolution Medicines (RVMD) from 2017 to 2025
Latest: $0.00
Revenue growth chart for Revolution Medicines (RVMD) from 2017 to 2025
Latest: -100.0%
Revenue history table for Revolution Medicines (RVMD) from 2017 to 2025
| 2025 | $0.00 | — | $0.00 | ||
| 2024 | $0.00 | -100.0% | −$11.58M | ||
| 2023 | $11.58M | -67.3% | −$23.80M | ||
| 2022 | $35.38M | +20.4% | +$5.99M | ||
| 2021 | $29.39M | -31.6% | −$13.59M | ||
| 2020 | $42.98M | -14.1% | −$7.06M | ||
| 2019 | $50.04M | +148.2% | +$29.88M | ||
| 2018 | $20.16M | — | +$20.16M | ||
| 2017 | $0.00 | — | — |
- 2025$0.00—
- 2024$0.00-100.0%
- 2023$11.58M-67.3%
- 2022$35.38M+20.4%
- 2021$29.39M-31.6%
- 2020$42.98M-14.1%
- 2019$50.04M+148.2%
- 2018$20.16M—
- 2017$0.00—
Revenue values are taken from Revolution Medicines's reported income statements (quarterly 10-Q and annual 10-K filings with the U.S. Securities and Exchange Commission). Each row shows the period end date and the filing date. YoY compares each figure to the same period one year earlier. Amounts are in USD as filed.
About Revenue at Revolution Medicines (RVMD)
According to Revolution Medicines's latest reported financial statements, the company's current revenue (TTM) is $0.00. Revenue is the total income from selling goods or services before any expenses. Unlike net income (earnings), revenue does not subtract operating costs, taxes, or other charges. Figures are in USD; chart and tables below use historical filings.
Headline TTM above sums the four reported quarters through (reported ). Chart and table below cover the full reported history back to .
Revolution Medicines (RVMD) most recent annual revenue stands at $0.00 (2025).
Across 2020–2025 (5 years), Revolution Medicines revenue produced a CAGR of -100.0% – with a net decline across the window.
Revolution Medicines revenue plunged from $50.04M in 2019 to $0.00 in 2025, a 100.0% drawdown.
$50.04M stands as the all-time-high annual revenue, posted in 2019, against a low of $0.00 during 2017.
Revolution Medicines Revenue by Year
Revolution Medicines Revenue 2025: $0.00
Revolution Medicines revenue in 2025 was $0.00.
Revolution Medicines Revenue 2024: $0.00
Revolution Medicines posted revenue of $0.00 in 2024, plunged 100.0% below 2023.
Revolution Medicines Revenue 2023: $11.58M
In 2023, Revolution Medicines reported revenue of $11.58M, plunged 67.3% below 2022.
Revolution Medicines Revenue 2022: $35.38M
Revolution Medicines revenue in 2022 was $35.38M, grew 20.4% from 2021.
Revolution Medicines Revenue 2021: $29.39M
Revolution Medicines revenue in 2021 was $29.39M.
See more financial history for Revolution Medicines (RVMD).
Sector peers by Revenue
Healthcare peers of Revolution Medicines (RVMD), ranked by their latest revenue
| $447.57B | |
| $94.19B | |
| $65.18B | |
| $64.93B | |
| $61.16B | |
| $58.74B | |
| $48.18B | |
| $36.74B |
- $447.57B
- $94.19B
- $65.18B
- $64.93B
- $61.16B
- $58.74B
- $48.18B
- $36.74B
Frequently asked questions
Revolution Medicines (RVMD) Key Financials
Charts, filings, and peer comparison for every metric
Explore more
Deep-dives across the income statement, cash flow, capital return, and valuation